

Nottingham University Hospitals NHS Trust has made a remarkably successful response to these new opportunities.
We are the host organisation for the Trent CLRN and topic specific research networks in Cancer and Medicines for Children, and is a hub for the Stroke Network.
In partnership with the University of Nottingham, we have secured:
This record is unmatched by any other organisation in the UK, and has resulted in more than £35M of new investment from the NIHR.
Against this background, the role of the Department of R&D in NUH has evolved. The first responsibility of R&D remains the provision of an excellent research support service. In addition, however, the Department has a new and complex range of resources, which will be strategically allocated and managed to support first class clinical research and to create sustainable research capacity in the organisation. The Trust is the custodian of NIHR investment intended to place NUH at the centre of the national programme to drive innovation in healthcare and translate advances in biomedical research into benefit for our patients. The role of the R&D department is to manage this resource effectively, to facilitate delivery of the experimental programmes and to provide a strong base for further large scale investment by the NIHR and other major funders.
For the R&D Strategy and details on the services and support we provide, please visit our main website www.nuhrise.org